Accelerate Diagnostics logo

Accelerate Diagnostics share price today

(AXDX)

Accelerate Diagnostics share price is $1.1 & ₹94.09 as on 30 Dec 2024, 20.28 hrs IST

$1.1

▲

-0.01

(-0.9%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Accelerate Diagnostics share price in Dollar and Rupees. Guide to invest in Accelerate Diagnostics from India. Also see the sentimental analysis on Indian investors investing in Accelerate Diagnostics. Get details on the Indian mutual funds that are investing in Accelerate Diagnostics. Get Analyst recommendations and forecasts along with all the Accelerate Diagnostics's financials.

Accelerate Diagnostics share price movements

  • Today's Low: $0.99
    Today's High: $1.11

    Day's Volatility :10.81%

  • 52 Weeks Low: $0.73
    52 Weeks High: $4.24

    52 Weeks Volatility :82.78%

Accelerate Diagnostics Returns

PeriodAccelerate Diagnostics IncSector (Health Care)Index (Russel 2000)
3 Months
-35.67%
-9.8%
0.0%
6 Months
-5.98%
-4.7%
0.0%
1 Year
-74.0%
1.9%
0.0%
3 Years
-97.89%
-1.8%
-21.3%

Accelerate Diagnostics Key Statistics

in dollars & INR

Previous Close
$1.1
Open
$1.07
Today's High
$1.112
Today's Low
$1.06
Market Capitalization
$27.8M
Today's Volume
$384.8K
52 Week High
$4.24
52 Week Low
$0.73
Revenue TTM
$12.2M
EBITDA
$-40.8M
Earnings Per Share (EPS)
$-2.59
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Accelerate Diagnostics from India?

It is very easy for Indian residents to invest directly in Accelerate Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Accelerate Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Accelerate Diagnostics or AXDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Accelerate Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Accelerate Diagnostics shares which would translate to 0.778 fractional shares of Accelerate Diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Accelerate Diagnostics, in just a few clicks!

Returns in Accelerate Diagnostics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Accelerate Diagnostics investment value today

Current value as on today

₹28,799

Returns

₹71,201

(-71.2%)

Returns from Accelerate Diagnostics Stock

₹73,995 (-74%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Accelerate Diagnostics

0%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Accelerate Diagnostics on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 0% more investors are searching Accelerate Diagnostics in the last 30 days versus the previous period.

Global Institutional Holdings in Accelerate Diagnostics

  • Armistice Capital, LLC

    8.39%

  • Hovey Youngman Associates Inc

    4.97%

  • Vanguard Group Inc

    1.89%

  • Geode Capital Management, LLC

    0.51%

  • Spears Abacus Advisors LLC

    0.46%

  • Tci Wealth Advisors Inc

    0.22%

Analyst Recommendation on Accelerate Diagnostics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Accelerate Diagnostics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Accelerate Diagnostics

What analysts predicted

Upside of 36.36%

Current:

$1.10

Target:

$1.50

Insights on Accelerate Diagnostics

  • Price Movement

    In the last 1 month, AXDX stock has moved down by -33.7%

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.98M → 2.97M (in $), with an average decrease of 0.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -11.58M → -14.63M (in $), with an average decrease of 26.3% per quarter

  • AXDX vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 56.8% return, outperforming this stock by 128.7%

  • AXDX vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 110.9% return, outperforming this stock by 208.7%

  • Price to Sales

    ForAXDX every $1 of sales, investors are willing to pay $1.7, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Accelerate Diagnostics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$5.7M
↑ 35.74%
Net Income
$-88.3M
↑ 40.46%
Net Profit Margin
-1.6K%
↓ 52.35%
FY19Y/Y Change
Revenue
$9.3M
↑ 63.97%
Net Income
$-84.3M
↓ 4.55%
Net Profit Margin
-906.8%
↑ 650.98%
FY20Y/Y Change
Revenue
$11.2M
↑ 20.09%
Net Income
$-78.2M
↓ 7.23%
Net Profit Margin
-700.47%
↑ 206.33%
FY21Y/Y Change
Revenue
$11.8M
↑ 5.53%
Net Income
$-77.7M
↓ 0.65%
Net Profit Margin
-659.5%
↑ 40.97%
FY22Y/Y Change
Revenue
$12.8M
↑ 8.23%
Net Income
$-62.5M
↓ 19.57%
Net Profit Margin
-490.06%
↑ 169.44%
FY23Y/Y Change
Revenue
$12.1M
↓ 5.43%
Net Income
$-61.6M
↓ 1.4%
Net Profit Margin
-510.97%
↓ 20.91%
Q2 FY23Q/Q Change
Revenue
$2.9M
↑ 3.88%
Net Income
$-26.0M
↑ 44.77%
Net Profit Margin
-889.42%
↓ 251.23%
Q3 FY23Q/Q Change
Revenue
$3.3M
↑ 12.94%
Net Income
$910.0K
↓ 103.5%
Net Profit Margin
27.58%
↑ 917.0%
Q4 FY23Q/Q Change
Revenue
$3.0M
↓ 9.06%
Net Income
$-13.0M
↓ 1528.57%
Net Profit Margin
-433.33%
↓ 460.91%
Q1 FY24Q/Q Change
Revenue
$2.9M
↓ 2.63%
Net Income
$-14.2M
↑ 9.46%
Net Profit Margin
-487.16%
↓ 53.83%
Q2 FY24Q/Q Change
Revenue
$3.0M
↑ 2.23%
Net Income
$-11.6M
↓ 18.57%
Net Profit Margin
-388.08%
↑ 99.08%
Q3 FY24Q/Q Change
Revenue
$3.0M
↓ 0.37%
Net Income
$-14.6M
↑ 26.33%
Net Profit Margin
-492.07%
↓ 103.99%
FY18Y/Y Change
Profit
$2.5M
↓ 21.8%
FY19Y/Y Change
Profit
$4.4M
↑ 77.2%
FY20Y/Y Change
Profit
$4.5M
↑ 1.34%
FY21Y/Y Change
Profit
$-381.0K
↓ 108.54%
FY22Y/Y Change
Profit
$3.3M
↓ 966.93%
FY23Y/Y Change
Profit
$2.6M
↓ 22.8%
Q2 FY23Q/Q Change
Profit
$799.0K
↓ 20.97%
Q3 FY23Q/Q Change
Profit
$107.0K
↓ 86.61%
Q4 FY23Q/Q Change
Profit
$606.0K
↑ 466.36%
Q1 FY24Q/Q Change
Profit
$723.0K
↑ 19.31%
Q2 FY24Q/Q Change
Profit
$676.0K
↓ 6.5%
Q3 FY24Q/Q Change
Profit
$856.0K
↑ 26.63%
FY18Y/Y Change
Operating Cash Flow
$-67.8M
↑ 21.54%
Investing Cash Flow
$-20.1M
↓ 21.73%
Financing Cash Flow
$125.8M
↑ 39.09%
FY19Y/Y Change
Operating Cash Flow
$-64.8M
↓ 4.37%
Investing Cash Flow
$52.8M
↓ 362.25%
Financing Cash Flow
$6.8M
↓ 94.58%
FY20Y/Y Change
Operating Cash Flow
$-50.4M
↓ 22.22%
Investing Cash Flow
$13.6M
↓ 74.24%
Financing Cash Flow
$11.6M
↑ 70.5%
FY21Y/Y Change
Operating Cash Flow
$-47.3M
↓ 6.09%
Investing Cash Flow
$8.3M
↓ 38.97%
Financing Cash Flow
$43.2M
↑ 271.58%
FY22Y/Y Change
Operating Cash Flow
$-48.7M
↑ 2.97%
Investing Cash Flow
$12.4M
↑ 49.53%
Financing Cash Flow
$31.6M
↓ 26.83%
Q2 FY23Q/Q Change
Operating Cash Flow
$-10.8M
↓ 19.04%
Investing Cash Flow
$915.0K
↓ 88.85%
Financing Cash Flow
$9.8M
↓ 12835.06%
Q3 FY23Q/Q Change
Operating Cash Flow
$-8.3M
↓ 23.74%
Investing Cash Flow
$-354.0K
↓ 138.69%
Financing Cash Flow
$-817.0K
↓ 108.33%

Accelerate Diagnostics Technicals Summary

Sell

Neutral

Buy

Accelerate Diagnostics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Accelerate Diagnostics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Accelerate Diagnostics Inc
Accelerate Diagnostics Inc
-33.33%
-5.98%
-74.0%
-97.89%
-99.35%
Stryker Corporation
Stryker Corporation
-5.78%
9.1%
23.93%
37.28%
74.44%
Boston Scientific Corp.
Boston Scientific Corp.
0.25%
18.65%
56.74%
113.42%
100.0%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
7.26%
-16.18%
0.11%
-41.61%
-2.39%
Abbott Laboratories
Abbott Laboratories
-1.56%
11.42%
4.68%
-18.3%
32.25%
Medtronic Plc
Medtronic Plc
-6.7%
4.69%
-2.54%
-21.95%
-29.52%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Accelerate Diagnostics Inc
Accelerate Diagnostics Inc
NA
NA
-0.55
0.0
0.0
-0.76
NA
-1.36
Stryker Corporation
Stryker Corporation
39.51
39.51
2.59
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
Boston Scientific Corp.
75.58
75.58
1.65
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
29.21
29.21
6.97
2.55
0.19
0.11
NA
16.18
Abbott Laboratories
Abbott Laboratories
34.95
34.95
2.23
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
Medtronic Plc
24.95
24.95
1.49
5.2
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Accelerate Diagnostics Inc
Accelerate Diagnostics Inc
Buy
$27.8M
-99.35%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$140.8B
74.44%
39.51
16.34%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$134.8B
100.0%
75.58
11.26%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$44.6B
-2.39%
29.21
65.86%
Abbott Laboratories
Abbott Laboratories
Buy
$199.4B
32.25%
34.95
13.99%
Medtronic Plc
Medtronic Plc
Buy
$104.6B
-29.52%
24.95
12.06%

About Accelerate Diagnostics

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Organization
Accelerate Diagnostics
Employees
134
CEO
Mr. Jack Phillips
Industry
Health Technology

Management People of Accelerate Diagnostics

NameTitle
Mr. Jack Phillips
CEO, President & Director
Mr. David Patience
Chief Financial Officer
Mr. Lawrence Michael Mertz
Chief Technology Officer
Ms. Maya Gowri
Senior VP & Head of Operations
Mr. John Meduri
Chief Strategy Officer
Mr. Chris Thode
Senior Vice President of US Commercial
Ms. Rita Boukamel
Senior VP & Head of EMEA

Important FAQs about investing in Accelerate Diagnostics from India :

What is Accelerate Diagnostics share price today?

Accelerate Diagnostics share price today stands at $1.10, Open: $1.07 ; Previous Close: $1.11 ; High: $1.11 ; Low: $0.99 ; 52 Week High: $4.24 ; 52 Week Low: $0.73. The stock opens at $1.07, after a previous close of $1.11. The stock reached a daily high of $1.11 and a low of $0.99, with a 52-week high of $4.24 and a 52-week low of $0.73.

Can Indians buy Accelerate Diagnostics shares?

Yes, Indians can invest in the Accelerate Diagnostics (AXDX) from India.

With INDmoney, you can buy Accelerate Diagnostics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Accelerate Diagnostics at zero transaction cost.

How can I buy Accelerate Diagnostics shares from India?

It is very easy to buy Accelerate Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Accelerate Diagnostics be purchased?

Yes, you can buy fractional shares of Accelerate Diagnostics with INDmoney app.

What are the documents required to start investing in Accelerate Diagnostics stocks?

To start investing in Accelerate Diagnostics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Accelerate Diagnostics

Today’s highest price of Accelerate Diagnostics (AXDX) is $1.11.

Today’s lowest price of Accelerate Diagnostics (AXDX) is $0.99.

What is today's market capitalisation of Accelerate Diagnostics

Today's market capitalisation of Accelerate Diagnostics AXDX is 27.8M

What is the 52 Week High and Low Range of Accelerate Diagnostics

  • 52 Week High

    $4.24

  • 52 Week Low

    $0.73

What are the historical returns of Accelerate Diagnostics?

  • 1 Month Returns

    -33.33%

  • 3 Months Returns

    -5.98%

  • 1 Year Returns

    -74%

  • 5 Years Returns

    -99.35%

Who is the Chief Executive Officer (CEO) of Accelerate Diagnostics

Mr. Jack Phillips is the current Chief Executive Officer (CEO) of Accelerate Diagnostics.